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Abstract
Introduction:	In	kindling,	repeated	electrical	stimulation	of	certain	brain	areas	causes	
progressive and permanent intensification of epileptiform activity resulting in general-
ized	 seizures.	We	 focused	 on	 the	 role(s)	 of	 glutamate	 and	 a	 negative	 regulator	 of	
	glutamate	release,	STXBP5/tomosyn-	1,	in	kindling.
Methods:	Stimulating	electrodes	were	implanted	in	the	amygdala	and	progression	to	
two	successive	Racine	stage	5	seizures	was	measured	in	wild-	type	and	STXBP5/to-
mosyn-	1−/−	 (Tom−/−)	 animals.	 Glutamate	 release	measurements	 were	 performed	 in	
distinct	brain	regions	using	a	glutamate-	selective	microelectrode	array	(MEA).
Results: Naïve Tom−/−	mice	had	significant	increases	in	KCl-	evoked	glutamate	release	
compared	 to	naïve	wild	 type	as	measured	by	MEA	of	presynaptic	 release	 in	 the	hip-
pocampal	 dentate	 gyrus	 (DG).	 Kindling	 progression	 was	 considerably	 accelerated	 in	
Tom−/−	mice,	requiring	fewer	stimuli	to	reach	a	fully	kindled	state.	Following	full	kindling,	
MEA	measurements	 of	 both	 kindled	Tom+/+ and Tom−/− mice showed significant in-
creases	in	KCl-	evoked	and	spontaneous	glutamate	release	in	the	DG,	indicating	a	corre-
lation with the fully kindled state independent of genotype. Resting glutamate levels in 
all hippocampal subregions were significantly lower in the kindled Tom−/−	mice,	suggest-
ing possible changes in basal control of glutamate circuitry in the kindled Tom−/− mice.
Conclusions: Our studies demonstrate that increased glutamate release in the hip-
pocampal	DG	correlates	with	acceleration	of	the	kindling	process.	Although	STXBP5/
tomosyn-	1	loss	increased	evoked	glutamate	release	in	naïve	animals	contributing	to	
their	prokindling	phenotype,	the	kindling	process	can	override	any	attenuating	effect	
of	STXBP5/tomosyn-	1.	Loss	of	this	“braking”	effect	of	STXBP5/tomosyn-	1	on	kindling	
progression	may	set	in	motion	an	alternative	but	ultimately	equally	ineffective	com-
pensatory	response,	detected	here	as	reduced	basal	glutamate	release.
K E Y W O R D S
epileptogenesis,	microelectrode,	SNAREs,	SV2,	synaptopathies
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1  | INTRODUCTION
Kindling is a process whereby repeated electrical stimulation of certain 
brain	areas,	particularly	the	limbic	system,	with	a	fixed	current	strength	
and duration causes progressive and permanent intensification of epi-
leptiform	activity	resulting	in	generalized	seizures	(Goddard,	McIntyre,	
&	Leech,	1969).	Kindling	in	rodents	has	been	well	characterized	both	
electrographically and behaviorally with progressive stages thought 
to	mimic	partial	 and	 secondary	generalized	human	epilepsy	 (Racine,	
1972).	Once	an	animal	reaches	a	fully	kindled	state,	kindling-	evoked	
seizures	readily	occur	for	the	rest	of	that	animal’s	life,	even	after	peri-
ods	of	abstinence	(Bertram,	2007;	Coulter,	McIntyre,	&	Loscher,	2002;	
Racine,	1972).	The	persistence	of	seizure	activity,	even	after	electrical	
stimulations	have	ceased,	is	thought	to	derive	from	robust,	permanent	
neurobiochemical	 changes	 in	 the	 brain;	 however,	 the	 exact	mecha-
nism	 is	unknown	 (McIntyre	&	Gilby,	2006).	Thus,	understanding	the	
molecular	mechanism	of	the	“kindling	phenomenon”	may	help	eluci-
date some of the molecular pathology of human epileptogenesis.
Synaptic	glutamate	release	is	an	intricate	and	highly	regulated	pro-
cess	that	includes	several	proteins,	which	facilitate	synaptic	vesicle	dock-
ing,	priming,	and	fusion	with	the	plasma	membrane	(Südhof,	2013).	The	
minimal	protein	requirements	needed	for	neurotransmitter	(NT)	release	
are	the	plasma	membrane-	bound	t-	SNAREs,	syntaxin	and	synaptosomal-	
associated	protein	25	(SNAP-	25),	and	the	vesicle-	bound	v-	SNARE,	syn-
aptobrevin/vesicle-	associated	membrane	 protein	 2	 (VAMP-	2)	 (Jahn	&	
Scheller,	2006).	Neuronal	depolarization	leads	to	an	increase	in	presyn-
aptic intracellular Ca2+ that promotes membrane fusion and NT release. 
Membrane	fusion	requires	the	formation	of	a	heterotrimer	of	these	pro-
teins,	 referred	 to	as	 the	7-	Svedberg	SNAP	 (soluble	N-	ethylmaleimide-	
sensitive	factor	[NSF]	attachment	protein)	receptor	(7S	SNARE)	complex	
(7SC)	(Brunger,	2005;	Jahn	&	Scheller,	2006;	Weber	et	al.,	1998).
Several	proteins	regulate	the	formation	of	the	7SC	and	thus	NT	re-
lease	(Lonart	&	Südhof,	2000).	These	proteins	include	those	that	affect	
the	dynamics	of	the	“readily	releasable	pool”	of	NT-	containing	vesicles,	
for	example,	Munc13s,	Complexins,	SV2s,	and	STXBP5/tomosyn-	1,	as	
well	as	those	that	recycle	SNARE	complexes,	for	example,	NSF	and	α-	
SNAP	(Ashery	et	al.,	2000;	Custer,	Austin,	Sullivan,	&	Bajjalieh,	2006;	
Hu	 et	al.,	 2002;	Whiteheart,	 Schraw,	 &	Matveeva,	 2001).	 STXBP5/
tomosyn-	1	is	thought	to	function	as	a	negative	regulator	of	SNARE-	
mediated	membrane	fusion,	primarily	by	sequestering	the	syntaxin-	1a	
and	 SNAP-	25	 heterodimer	 and	 inhibiting	 7SC	 formation	 (Ashery,	
Bielopolski,	Barak,	&	Yizhar,	2009;	Sakisaka	et	al.,	2008;	Willams	et	al.,	
2011).	 STXBP5/tomosyn-	1’s	 C-	terminal	 VAMP-	like	 domain	 binds	
the	 t-	SNARE	 heterodimer	 and	 regulates	 access	 to	 v-	SNAREs.	 Two	
isoforms,	 tomosyn-	1	and	 tomosyn-	2,	 are	preferentially	expressed	 in	
the	neuronal	synapse	(Yokoyama,	Shirataki,	Sakisaka,	&	Takai,	1999).	
STXBP5/tomosyn-	1	 is	 highly	 expressed	 in	 glutamatergic	 synapses	
with	differential	expression	within	these	synapses	in	the	mouse	hip-
pocampus	 (Barak	 et	al.,	 2010;	 Yokoyama	 et	al.,	 1999).	 Several	 ex-
perimental	 models	 show	 that	 loss	 of	 STXBP5/tomosyn-	1	 increases	
neurotransmitter	release,	excitatory	postsynaptic	potentials,	and	de-
creases	 odor	 memory	 (Chen,	 Richlitzki,	 Featherstone,	 Schwarzel,	 &	
Richmond,	2011;	Dybbs,	Ngai,	&	Kaplan,	2005;	Gracheva	et	al.,	2007;	
Sakisaka	 et	al.,	 2008),	 consistent	 with	 STXBP5/tomosyn-	1	 being	 a	
negative regulator of neurotransmitter release.
Given	 its	 role	 in	 neurotransmitter	 release,	 STXBP5/tomosyn-	1	 is	
an ideal target to manipulate presynaptic glutamatergic neurotransmis-
sion to understand how glutamatergic neurotransmission contributes 
to	kindling-	induced	epilepsy.	Here	we	report	the	use	of	glutamate	bi-
osensors	with	high	temporal	and	spatial	resolution	to	measure	resting,	
spontaneous,	 and	 evoked	 glutamate	 from	 hippocampal	 subregions	
(dentate	 gyrus	 [DG],	 CA3,	 and	 CA1)	 in	 naïve	 and	 kindled	wild-	type	
(Tom+/+)	and	knockout	(Tom−/−)	mice.	Our	results	show	that	Tom−/− mice 
have	a	kindling-	sensitive	phenotype	and	that	naïve	Tom−/− mice have 
higher	 KCl-	evoked	 glutamate	 release	 before	 kindling.	 However,	 the	
fully	kindled	state	alone	is	associated	with	significantly	enhanced	KCl-	
evoked and spontaneous glutamate release in the DG compared to all 
other	brain	regions	in	both	kindled	and	naïve	mice.	Interestingly,	basal	
glutamate levels were lower in kindled Tom−/− mice suggesting a com-
pensatory mechanism that may be triggered by kindling progression. 
These	results	suggest	that	a	critical	factor,	possibly	a	driver,	in	the	kin-
dling	phenomenon	(and	potentially	in	epileptogenesis)	is	the	evolution	
of	increased	glutamate	release	in	the	hippocampal	DG;	however,	once	
a	fully	kindled	state	is	reached,	STXBP5/tomosyn-	1	may	not	be	import-
ant in modulating glutamate release and maintaining the kindled state.
2  | MATERIALS AND METHODS
2.1 | Preparation of kindled and control animals and 
tissues
2.1.1 | Animals
The	STXBP5/Tom−/−	mice	on	a	50%	129Sv,	25%	C57BL/6,	and	25%	
DBA/2	background	were	generated	as	described	previously	(Sakisaka	
et	al.,	2008)	and	kindly	provided	by	Dr.	Yoshimi	Takai	(Department	of	
Biochemistry	and	Molecular	Biology,	Kobe	University	Graduate	School	
of	Medicine,	Kobe,	Japan).	All	work	with	animals	was	done	with	ap-
proval	from	the	University	of	Kentucky	IACUC.	Genotyping	was	per-
formed	by	PCR	using	DNA	prepared	from	tail	biopsies	(Sakisaka	et	al.,	
2008);	wild-	type	 littermates	were	 used	 as	 controls.	 These	 STXBP5/
Tom−/−	mice	were	 shown	 to	be	 lacking	 tomosyn-	1,	 but	 none	of	 the	
other	 elements	 of	 the	 secretory	machinery	 by	 quantitative	western	
blotting	of	different	tissues	(Sakisaka	et	al.,	2008;	Ye	et	al.,	2014).	For	
the	 kindling	 progression	 data,	 14	 Tom+/+ and 15 Tom−/− mice were 
used.	Six	naïve	Tom+/+ and five Tom−/− mice were used in collection of 
the	naïve	glutamate	data.	For	glutamate	measurements	in	kindled	mice,	
six	fully	kindled	mice	were	used	and	were	compared	to	the	naïve	mice	
above	(n	=	11)	(see	below	and	in	figure	captions	for	further	details).
2.1.2 | Surgical preparation for kindling electrode
Surgery	 was	 performed	 in	 a	 David	 Kopf	 stereotaxic	 apparatus	 fit-
ted with a mouse nose cone adapter. Mice were anesthetized and 
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maintained	 with	 2%–3%	 isoflurane	 during	 surgery.	 Teflon-	coated,	
stainless steel bipolar twisted electrodes were implanted in the right 
amygdala	 using	 coordinates	 from	 bregma	 (AP:	 −1.5;	ML:	 +3.5;	DV:	
−4.6)	and	adapted	from	Paxinos	and	Franklin	(2003).	Animals	recov-
ered	for	10–14	days,	postsurgery,	prior	to	initiation	of	kindling.	A	ran-
dom sampling from each group of treated animals was processed for 
histological	analysis	to	assess	electrode	placement.	Surgery	specifics	
have	been	described	previously	(Matveeva,	Vanaman,	Whiteheart,	&	
Slevin,	2007;	Slevin	&	Ferrara,	1985).
2.1.3 | Kindling techniques
All	 kindling	 methods	 have	 been	 described	 previously	 (Matveeva,	
Whiteheart,	 &	 Slevin,	 2003).	 Briefly,	 animals	 were	 tested	 for	 their	
after-	discharge	 (AD)	 threshold	 prior	 to	 kindling	 using	 a	 Grass	 S88	
stimulator	and	an	EEG.	Once	 the	AD	was	determined	 for	each	ani-
mal	it	was	used	to	stimulate	that	respective	animal	once/day,	5	days/
week.	Full	kindling	for	this	study	was	operationally	defined	as	a	Racine	
(1972)	stage	5	seizure,	consisting	of	rearing	and	falling,	occurring	after	
administration	 of	 two	 consecutive	 stimuli.	 No	 animals	 experienced	
any behavioral signs of a seizure 1 week prior to analysis; this was 
determined	by	daily	inspection	of	cages.	However,	split	screen	video	
electroencephalographic	(SSV-	EEG)	surveillance	was	not	used;	there-
fore,	 a	 seizure	 may	 have	 gone	 undetected.	 However,	 spontaneous	
seizures	rarely	occur	unless	the	subject	receives	“extended	kindling,”	
a process that typically involves hundreds of spaced electrical stimu-
lations	 (Bertram,	2007).	As	 the	animals	experienced	only	 two	 stage	
5	seizures,	 it	 is	 less	 likely	 than	not	 that	 they	experienced	a	sponta-
neous	seizure.	That	said,	 the	Tom−/− mice were more easily kindled 
and	 thereby	 more	 likely	 to	 have	 spontaneous	 seizures,	 even	 after	
experiencing	only	two	stage	5	seizures.	Previously,	we	demonstrated	
that	a	generalized	seizure	per	se	does	not	affect	the	7SC	ratio	in	rats	
(Matveeva	et	al.,	2003),	thus	even	if	a	seizure	occurred	it	 is	unlikely	
that it confounded our biochemical measurements.
2.1.4 | In vivo glutamate measurements
Enzyme-	based	biosensors	selective	for	glutamate	were	used	to	meas-
ure	resting	and	evoked	glutamate	in	vivo.	Thirty	days	after	experienc-
ing	two	consecutive	Racine	stage	5	seizures,	mice	were	anesthetized	
using isoflurane and glutamate measurements were collected using 
methods	adapted	from	Matveeva	et	al.	(2012);	this	was	a	nonsurvival	
surgery.
2.1.5 | Preparation of glutamate biosensors
Microelectrode	arrays	 (MEAs)	 consisting	of	 four	platinum	 recording	
sites 20 μm × 150 μm arranged in dual pairs were adapted to selec-
tively	measure	glutamate.	A	roughly	5	μl	mixture	of	1%	bovine	serum	
albumin	 (BSA),	 0.125%	 glutaraldehyde,	 and	 1%	 glutamate	 oxidase	
(GluOx)	was	manually	placed	(~0.1	μl	drop)	on	the	bottom	two	plati-
num	 recording	 sites	 using	 a	 gastight	 Hamilton® syringe. Glutamate 
oxidase	(GluOx)	breaks	down	glutamate	into	α-	ketoglutarate	and	the	
recorder	molecule,	H2O2,	which	is	oxidized	at	the	electrode	surface.	
The	same	procedure	was	used	to	apply	1%	BSA	and	0.125%	glutar-
aldehyde	on	the	top	two	sites	of	the	electrode,	which	allows	for	self-	
referencing	 as	 described	 previously	 (Burmeister	 &	 Gerhardt,	 2001;	
Day,	 Pomerleau,	 Burmeister,	 Huettl,	 &	 Gerhardt,	 2006).	 After	 the	
MEAs	were	coated,	they	were	cured	for	>72	hr	and	then	plated	with	
m-	phenylenediamine	(mPD),	a	size	exclusion	layer,	to	allow	for	more	
selective	glutamate	measurements.	The	mPD	(5	mmol/L)	solution	was	
made	 in	 deoxygenated	 phosphate-	buffered	 saline	 (PBS).	 The	 MEA	
was	then	connected	to	the	FAST	16	MKII	potentiostat	system	(Fast	
Analytical	Sensing	Technology	Mark	II,	Quanteon,	LLC)	and	the	four	
platinum sites of the electrode were submerged in the mPD solution. 
The platinum recording sites of the electrode were plated with mPD 
for 10–20 min via the electroplating tool built into the software and 
they	were	allowed	to	sit	for	>24	hr	before	use.
2.1.6 | MEA placement and in vivo recordings 
under anesthesia
All	mice	were	anesthetized	using	1%–3%	isoflurane,	placed	in	a	stere-
otaxic	 frame	 (David	Kopf	 Instruments,	 Tujunga,	CA),	 and	 a	bilateral	
craniotomy	was	performed	exposing	both	overlying	hemispheres	of	
the	bilateral	hippocampi.	For	kindled	mice,	the	kindling	head	cap	was	
removed	once	 the	mice	were	placed	 in	 the	 stereotaxic	 frame,	 then	
the bilateral craniotomy was performed. Body temperature was main-
tained at 37°C using a circulating water bath attached to a water pad 
(Gaymar	 Industries,	Orchard	Park,	NY).	A	small	burr	hole	was	made	
anterior	to	the	site	of	the	craniotomy	and	a	small	Ag/AgCl	reference	
electrode was implanted into the brain. Glutamate measurements for 
resting,	 spontaneous,	 and	 potassium-	evoked	 release	 of	 glutamate	
were recorded from discrete subregions of the hippocampus including 
the	DG	(AP:	−2.3;	ML:	±1.5;	DV:	−2.1),	CA3	(AP:	−2.3;	ML:	±2.7;	DV:	
−2.25),	 and	CA1	 (AP:	−2.3;	ML:	±1.7;	DV:	−1.4).	Anterior–posterior	
and	medial–lateral	coordinates	for	MEA	implantation	were	calculated	
relative to bregma and dorsal–ventral coordinates were taken from 
the	surface	of	the	brain	(Paxinos	&	Franklin,	2003).	A	prepulled	sin-
gle	 barrel	 glass	micropipette	 (inner	 diameter	 ~10	μm;	A-	M	Systems	
Inc.,	Everett,	WA)	was	used	to	locally	apply	KCl	in	distinct	hippocam-
pal	 subregions	 to	 measure	 stimulus-	evoked	 glutamate	 release.	 The	
micropipette was positioned in the center of the four pairs of plati-
num recording sites at a height between 50–100 μm,	 and	 attached	
to	 the	 electrode	 using	 Sticky	Wax	 (Kerr	 Lab	 Corporation,	 Orange,	
CA).	The	micropipette	attached	to	the	MEA	was	then	filled	with	fil-
tered	70	mmol/L	KCl	 (70	mmol/L	KCl,	79	mmol/L	NaCl,	2.5	mmol/L	
CaCl2;	pH	7.4)	and	the	MEA	was	attached	to	the	stereotaxic	frame.	
The	 micropipette	 was	 then	 attached	 to	 a	 Picospritzer	 III	 (Parker	
Hannifin	 Corporation,	 NJ)	 via	 rubber	 tubing	 to	 control	 the	 volume	
of	KCl	ejected	into	each	subregion	of	the	hippocampus.	A	stereomi-
croscope,	equipped	with	a	reticule,	was	used	to	monitor	the	volume	
of	KCl	ejected	 (Friedemann	&	Gerhardt,	1992).	Note	that	DG,	CA3,	
and	 CA1	 glutamate	 measurements	 were	 taken	 from	 all	 animals	 in	
both brain hemispheres and electrode placement for all brain regions 
were	counterbalanced,	thus	there	should	be	no	order	effects	 in	our	
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measurements.	Furthermore,	both	basal	glutamate	and	spontaneous	
release measures were taken before KCl was ejected in each brain re-
gion,	thus	KCl	application	did	not	affect	these	measurements.	It	is	also	
worth noting that basal measurements and spontaneous measure-
ments are functionally distinct: basal measurements are true resting 
levels,	whereas	spontaneous	measures	are	glutamate	release	events	
that occur during no KCl stimulation.
Electrode	placement	was	assessed	after	the	MEA	recordings	were	
completed.	 Specifically,	 the	 micropipette	 was	 filled	 with	 green	 ink	
(Special	Green	Ink;	KOH-	I-	NOOR	Co.),	placed	back	 in	the	hippocam-
pal	subregions	where	glutamate	recordings	were	done,	and	the	ink	was	
locally	ejected.	After	MEA	recordings,	animals	were	euthanatized	and	
brains were removed and flash frozen; 40 μm slices were obtained using 
a	cryostat.	The	slices	were	stained	using	Cresyl	violet	(Sigma-	Aldrich)	
and	were	imaged	to	confirm	MEA	placement	(Figure	1	left	and	right).
2.2 | Data analyses
2.2.1 | Kindling and glutamate analysis
After-	discharge	 thresholds	 and	 number	 of	 stimulations	 for	 kindled	
Tom+/+ and Tom−/− mice were each analyzed by the Mann–Whitney 
U test because the data were not normally distributed and violated 
homogeneity	of	variance.	The	ipsilateral/contralateral	7SC	band	inten-
sity ratios of kindled mice were analyzed using the Mann–Whitney U 
test because the data were not normally distributed and violated ho-
mogeneity	 of	 variance.	 The	 quantified	 secretory	machinery	 proteins	
from	kindled	hippocampi	were	analyzed	by	ANOVA.	The	amperometric	
data collected in naïve and kindled Tom+/+ and Tom−/− mice were ana-
lyzed	using	custom	exported	Excel™-	based	software	 (Quanteon	LLC,	
Lexington,	 KY).	 The	 parameters	 were	 resting	 (μmol/L),	 spontaneous	
(mol/L),	and	KCl-	evoked	glutamate	release	(mol/L),	as	well	as	the	time	
to	rise	of	the	evoked	glutamate	peak	(Trise;	s),	the	time	to	80%	decay	
of	 the	evoked	glutamate	peak	 (T80;	s),	 the	slope	of	 the	 linear	 regres-
sion	of	the	natural	log	transformation	of	the	decay	over	time	(k−1; s
−1),	
and	the	peak	area	under	the	evoked	glutamate	peak	 (area	under	the	
curve	[AU])	(Hascup	et	al.,	2007;	Hinzman	et	al.,	2010;	Matveeva	et	al.,	
2012).	 For	 resting	 levels	 and	 spontaneous	 release	 events,	 averages	
were taken after the electrode reached a stable baseline for at least 
30 min and before any KCl was used to stimulate the system in a given 
brain	area.	After	resting	data	were	collected,	100	nl	of	70	mmol/L	KCl	
was ejected in each brain area to evoke glutamate release; the peak 
amplitude concentration of glutamate release as well at the Trise,	T80,	
k−1,	and	peak	area	measurements	 in	each	brain	area	 is	an	average	of	
three	evoked	peaks.	For	all	glutamate	measurements	the	background	
current from the sentinel sites was subtracted from the current 
	measured	 at	 the	GluOX-	coated	 sites	 for	 a	more	 accurate	 glutamate	
measure in micromolar concentrations. The differences in naïve Tom+/+ 
and naïve Tom−/−	 glutamate	 release	were	 analyzed	using	 a	 two-	way	
mixed	ANOVA.	Analysis	of	 the	 relationships	between	genotype,	kin-
dling,	brain	area,	 and/or	hemisphere	was	analyzed	using	an	omnibus	
(four-	way)	ANOVA.	Where	appropriate,	a	Bonferroni	correction	post	
hoc	analysis	was	used	to	probe	interactions.	Statistical	significance	was	
determined as p < .05 for all analyses. Note that no genotype effects 
were	seen	 in	kindled	animals	for	the	glutamate	measurements.	Thus,	
all	glutamate	measurements	are	collapsed	across	genotype,	hence	the	
kindled glutamate figures only show comparisons between naïve and 
kindled animals with no regard to genotype.
2.2.2 | Analysis of 7S SNARE complexes (7SC) and 
SNARE regulators
All	animals	were	analyzed	approximately	30	days	after	experiencing	
two	Racine	stage	5	seizures.	For	some,	 tissue	was	harvested	after	
MEA	 measurements.	 Animals	 were	 euthanatized	 by	 decapitation	
and	their	brains	were	removed	and	the	hippocampi	excised	on	ice.	
Percoll	 gradient-	purified	 synaptosomes	 were	 prepared	 from	 indi-
vidual	hippocampi	as	previously	described	(Dunkley,	Jarvie,	Heath,	
Kidd,	&	Rostas,	1986;	Dunkley	et	al.,	1988).	Synaptosome	extracts	
were	prepared	by	incubating	equal	quantities	of	synaptosomal	pro-
tein in sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-	PAGE)	sample	buffer	for	30	min	at	37°C;	under	these	condi-
tions	monomeric	SNAREs	are	denatured,	but	 the	7SC	 is	 thermally	
stable	and	fails	to	disassemble	(Matveeva	et	al.,	2003).	Upon	comple-
tion	of	electrophoresis	and	transfer	to	PVDF	membranes	(Millipore),	
these	complexes	were	probed	by	western	blotting	using	antibodies	
F IGURE  1 Representative	histology	of	glutamate	biosensor	placement	in	mouse	hippocampal	subregions.	After	completion	of	electrochemical	
recordings	green	ink	was	ejected	into	each	hippocampal	subregion	where	recordings	occurred	to	confirm	electrode	placement.	Shown	are	
micrographs of 40 μm	coronal	sections	stained	with	Cresyl	violet.	Left	figure:	Dorsal–ventral	placement	of	the	electrode	for	glutamate	measurements	
in	the	CA3	and	CA1.	Right	figure:	Dorsal–ventral	placement	of	the	electrode	for	glutamate	measurements	in	the	DG.	Scale	bar	=	500	μm
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against	 the	 t-	SNARE,	syntaxin	1	 (HCP-	1;	 Inoue	&	Akagawa,	1992)	
as	described	previously	 (Matveeva	et	al.,	 2003).	Detection	of	7SC	
was	 performed	 using	 alkaline	 phosphatase-	coupled	 secondary	 an-
tibodies	 with	 Vistra	 ECF™	 for	 visualization	 and	 images	 were	 ob-
tained	using	a	Typhoon	9400	imager	(GE	Healthcare	Bio-	Sciences,	
Piscataway,	NJ).	The	 raw	data	 collected	were	 the	 integrated	 fluo-
rescence	 intensities	for	all	pixels	 in	a	given	protein	band	as	deter-
mined	 by	 ImageQuant	 5.2	 software	 (GE	 Healthcare	 Bio-	Sciences,	
Piscataway,	NJ)	 in	arbitrary	units.	To	normalize	for	protein	 loading	
the	fluorescence	intensity	of	all	7SC	bands	was	standardized	to	the	
intensity	of	 the	 syntaxin-	1	monomer	as	 in	Matveeva	et	al.	 (2011).	
The	7SC	complex	was	then	analyzed	by	comparing	the	relative	ratio	
of protein from the ipsilateral hippocampus compared to the con-
tralateral	 hippocampus	 (ipsilateral/contralateral)	 for	 both	 kindled	
genotypes	 using	 the	 following	 equation:	 [7SC	 ipsilateral/syntaxin-
	1]/[7SC	contralateral/syntaxin-	1].
Other	secretory	machinery	proteins	were	analyzed	as	above.	NSF	
was	 detected	 with	 the	 2E5	 monoclonal	 antibody	 (Tagaya,	 Wilson,	
Brunner,	 Arango,	 &	 Rothman,	 1993;	 Whiteheart	 et	al.,	 1994).	 The	
monoclonal	antibody	 to	SV2	 (which	detects	both	A	and	B	 isoforms)	
was	obtained	from	the	Developmental	Studies	Hybridoma	(Iowa	City,	
IA).	Fluorescence	intensities	of	the	bands	in	each	lane	were	normalized	
to	the	intensity	of	the	syntaxin-	1	band	in	the	same	lane.	To	determine	
“protein	laterality”	(relative	amount	of	protein	in	ipsilateral	vs.	contra-
lateral	hippocampus),	the	following	equation	was	used:	[(contralateral/
syntaxin-	1	+	ipsilateral/syntaxin-	1)/2]/(mean	 contralateral	 control/
syntaxin-	1).	If	no	changes	in	protein	level	occur,	then	the	ratio	should	
be one. Note these methods are based on the previously published 
work	(Matveeva	et	al.,	2007).
3  | RESULTS
3.1 | Effect of STXBP5/tomosyn- 1 on kindling
Considering	 STXBP5/tomosyn-	1’s	 role	 as	 a	 negative	 regulator	 of	
glutamate	 release,	 we	 chose	 to	 first	 assess	 if	 Tom−/− mice had a 
kindling-	sensitive	 phenotype,	 which	 would	 suggest	 that	 dysregula-
tion of glutamate release contributes to epileptogenesis. Kindling 
was induced much more rapidly in Tom−/− mice compared to controls. 
Fewer	 stimulations	 were	 required	 to	 reach	 a	 fully	 kindled	 state	 in	
Tom−/−	animals	than	in	control	mice	(Figure	2a).	However,	there	were	
no	 significant	 differences	 in	 the	AD	 threshold	 current	 between	 the	
two	 genotypes	 (Figure	2b).	 In	 addition	 to	 association	with	 an	 initial	
inhibition	of	kindling	onset,	STXBP5/tomosyn-	1	appears	to	retard	the	
development	of	 kindling	as	depicted	 in	Figure	2c,	where	 the	 slopes	
of kindling evolution between the populations of Tom+/+ and Tom−/− 
mice are different.
3.2 | Alterations in the secretory machinery in 
kindled mice
To determine if the biochemical changes we previously identified 
(Matveeva,	 Vanaman,	Whiteheart,	 &	 Slevin,	 2008;	Matveeva	 et	al.,	
2003,	2007,	2011,	2012)	were	occurring	in	this	model,	we	assessed	
the	7SC	complex	formation	and	the	levels	of	specific	proteins	(SV2;	
NSF)	1	month	following	full	kindling	as	operationally	defined.	Table	1	
shows protein analysis of various components of the neurosecretory 
machinery from both kindled Tom+/+ and Tom−/−	mice.	For	a	given	pro-
tein	determination,	prior	MEA	measurements	in	animals	of	a	specific	
genotype	made	no	difference;	hence,	the	values	in	Table	1	are	from	
animals	±	MEA	measurements.	As	seen	previously,	there	was	an	ipsi-
lateral	increase	in	7SC,	but	there	was	no	significant	genotype-	specific	
difference	(note	that	both	ratios	are	above	one	in	both	genotypes	sug-
gesting	only	a	kindling	effect).	Similarly,	total	levels	of	SV2	increased	
and	NSF	decreased	in	both	kindled	Tom+/+ and Tom−/−	mice,	as	previ-
ously	reported	for	other	kindling	models	(Matveeva	et	al.,	2007;	Ohno	
et	al.,	 2009).	 There	 was	 no	 significant	 genotype-	specific	 difference	
as	seen	by	the	fact	 the	NSF	and	SV2	 levels	 for	both	genotypes	are	
F IGURE  2 Mice	lacking	STXBP5/tomosyn-	1	kindle	faster	than	
wild-	type	mice.	(a)	The	average	number	stimulations	(once	per	day)	
required	to	obtain	a	stage	5	seizure	on	2	consecutive	days.	Data	
are	presented	as	mean	±	SEM; n = 14 for Tom+/+ mice and n = 15 
for Tom−/− mice [U = 31,	*p = .0028,	Mann–Whitney	U	test).	(b)	The	
average	current	required	to	produce	an	AD	for	Tom+/+ versus Tom−/− 
mice	(U = 81,	p = .67,	Mann–Whitney	U	test).	(c)	Time	course	to	
cumulatively	reach	a	Racine	stage	5	seizure	(1	stimulation	per	day)	for	
Tom+/+	(grey	line,	n	=	14)	and	Tom−/−	(black	line,	n	=	15)	mice.	Note	
the 50% line corresponds to the average number of stimulations seen 
for	each	genotype	in	(a)
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below	one	and	above	one,	respectively,	again	suggesting	only	a	kin-
dling effect.
3.3 | Functional correlates of kindling, STXBP5/
tomosyn-1 deficiency, and glutamate dynamics
The	data	above	suggested	that	STXBP5/tomosyn-	1	may	act	to	miti-
gate	 kindling	 considering	 mice	 lacking	 STXBP5/tomosyn-	1	 express	
a	 kindling-	sensitive	 phenotype.	 Our	 group	 and	 others	 previously	
showed that glutamate release dynamics are changed in kindled rats 
(Matveeva	et	al.,	2012;	Sun	et	al.,	2013),	 thus	 it	 is	possible	 that	 the	
kindling-	sensitive	phenotype	 seen	 in	Tom−/−	animals	 is,	 in	part,	due	
to glutamate system dysregulation through alterations in glutamate 
release.	We	assessed	whether	STXBP5/tomosyn-	1	loss	and	kindling	
affected glutamate neurotransmission in distinct hippocampal subre-
gions in vivo in Tom+/+ and Tom−/−	mice	by	measuring	extracellular	
resting	 glutamate,	 spontaneous	 and	 KCl-	evoked	 glutamate	 release,	
and the Trise,	T80,	k−1,	and	peak	area	of	the	evoked	peak	(Hascup	et	al.,	
2007,	2011;	Hinzman	et	al.,	2010;	Matveeva	et	al.,	2011,	2012).
Consistent	with	STXBP5/tomosyn-	1’s	role	as	a	negative	regulator	
of	NT	release,	the	KCl-	evoked	glutamate	release	was	greater	in	the	DG	
of naïve Tom−/− mice compared to naïve Tom+/+	mice	(Figure	3).	Other	
hippocampal	 regions	showed	no	genotype-	dependent	differences	 in	
KCl-	evoked	glutamate	release.	There	were	also	no	differences	in	basal,	
spontaneous	release,	Trise,	T80,	k−1,	or	peak	area	measures	in	naïve	mice	
(Table	2).
Loss	of	SXTBP5/tomosyn-	1	did	not	affect	the	amplitudes	of	spon-
taneous,	transient	glutamate	release;	however,	kindling	did	have	an	ef-
fect,	regardless	of	genotype	(Figure	4).	There	were	significantly	larger	
spontaneous peaks in the DG ipsilateral to the kindling electrode com-
pared	 to	all	other	brain	 regions	except	 for	 the	kindled,	contralateral	
CA1.	We	previously	observed	similar	spontaneous	changes	in	kindled	
rats	 (Matveeva	et	al.,	2011),	 indicating	that	heightened	spontaneous	
synaptic glutamatergic activity in DG correlates with kindling in ro-
dents and suggests it may be universal across species.
There	was	a	genotype-	independent	 increase	 in	the	amplitude	of	
KCl-	evoked	glutamate	release	in	the	DG	(both	hemispheres)	of	kindled	
animals compared to kindled and nonkindled animals across all hip-
pocampal	subregions	(Figure	5a	and	b;	average	data	collapsed	across	
hemispheres	due	to	the	lack	of	a	hemisphere	effect).	Analysis	of	Trise,	
T80,	k−1,	and	peak	area	of	the	evoked	glutamate	peaks	showed	no	sig-
nificant	differences,	suggesting	no	change	in	release	mechanism,	just	
the	quanta	of	release	events	 (Table	2).	 Interestingly,	resting	 levels	of	
glutamate were significantly reduced in kindled Tom−/− mice compared 
to kindled Tom+/+ mice suggesting that there is a decrease in the basal 
extracellular	concentration	of	glutamate	released	in	the	hippocampus	
of kindled Tom−/−	mice	(Table	3).
4  | DISCUSSION
The most widely used models of epileptogenesis include electrical kin-
dling,	poststatus	epilepticus	(SE;	chemical	kindling	with,	e.g.,	kainate	
or	 pilocarpine)	models	 of	 temporal	 lobe	 epilepsy	 (TLE),	 and	models	
of	 traumatic	brain	 injury-	induced	epilepsy	 (Kharatishvili	&	Pitkanen,	
2010;	Loscher	&	Brandt,	2010;	Stables	et	al.,	2002).	Post-	SE	chemical	
kindling	models,	 in	which	 the	 acute	 triggering	 process	 of	 SE	 is	 fre-
quently	followed	by	a	latency	period	with	subsequent	development	of	
spontaneous	motor	seizures,	closely	mimic	the	clinical	manifestations	
of	human	TLE	and	electrical	 kindling.	Recordings	 from	 intracerebral	
implanted electrodes demonstrate that the first electrographic abnor-
malities	in	TLE	without	mesial	temporal	sclerosis	(MTS)	often	appear	
within	hippocampus	(Van	Roost,	Solymosi,	Schramm,	van	Oosterwyck,	
&	Elger,	1998).	This	suggests	that	network	changes	in	the	hippocam-
pal	formation	are	important	in	epileptogenesis,	but	that	morphological	
changes	such	as	MTS	while	perhaps	augmenting	the	process	are	not	
essential	(Thom,	2014;	Wang,	Smith,	Murphy,	&	Cook,	2010).	A	major	
drawback	to	all	post-	SE	chemical	kindling	models	 is	that	the	epilep-
togenesis	associated	with	most	TLE	is	not	initiated	by	an	episode	of	
status	epilepticus,	raising	the	question:	what	changes	are	primary	to	
TABLE  1 Whole	hippocampal	7SC	and	selected	regulatory	
exocytic	protein	measures	in	kindled	Tom+/+ and Tom−/− mice 
(mean	±	SEM)
Kindled Tom+/+ (n)
Kindled 
Tom−/− (n)
7	SCa 1.3	±	0.16	(8) 1.04	±	0.13	(11)
NSFb 0.81	±	0.35	(3) 0.95	±	0.23	(5)
SV2b 1.22	±	0.13	(7) 1.21	±	0.12	(6)
aRatio	=	[7SC	ipsilateral/syntaxin	1]/[7SC	contralateral/syntaxin	1],	where	
unity	is	expected.
bTotal	 SV2	 protein	=	[(contralateral/syntaxin	 1	+		 ipsilateral/syntaxin	
1)/2]/(mean	 contralateral	 control/syntaxin	 1)].	 If	 no	 changes	 in	 protein	
level	occur,	then	the	ratio	should	be	unity.
F IGURE  3 KCl-	evoked	glutamate	release	in	the	hippocampus	of	
naïve	wild-	type	and	STXBP5/tomosyn-	1	null	mice.	All	measurements	
are	presented	as	mean	±	SEM and were collected in naïve Tom+/+ 
(n	=	6)	and	Tom−/−	(n	=	5)	mice.	KCl-	evoked	glutamate	release	is	
higher in the DG of naïve Tom−/−	mice	(black	bars)	compared	to	the	
DG in Tom+/+	mice	(hatched	bars).	There	were	no	difference	in	CA3	
or	CA1	glutamate	release	between	the	two	genotypes	[F(2,	18)	=	7.1,	
*p = .0054;	Bonferroni	correction]
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epileptogenesis and what are epiphenomena to the model? The in-
tent of this study was to evaluate alterations in potential hippocampal 
network changes occurring at the level of synaptic neurotransmis-
sion.	We	chose	to	perform	electrical	kindling,	operationally	defining	
full	kindling	as	two	stage	5	seizures,	to	create	a	state	where	network	
change has occurred without gross morphological or inflammatory 
changes.	In	this	regard,	Osawa,	Uemura,	Kimura,	and	Sato	(2001)	have	
demonstrated	that	in	the	case	of	amygdalar	stimulation,	kindling	de-
velops without evidence of mossy fiber sprouting until after repeated 
kindled	convulsions,	following	death	of	granule	cells	in	the	DG.	In	their	
study,	animals	experienced	29	ADs	and	two	stage	5	kindled	convul-
sions	 before	 these	 histopathological	 changes	were	 seen.	 Amygdala	
kindled Tom−/−	mice	in	this	study	experienced	an	average	of	five	ADs	
(one	animal	had	9)	and	two	kindled	convulsions.	Tom+/+ mice had an 
average	of	10	ADs	(one	animal	had	18)	and	two	kindled	convulsions.	
The	literature	would	suggest	that	neither	genotype,	but	in	particular	
the Tom−/−	mice,	experienced	a	sufficient	number	of	ADs	and	kindled	
convulsions to have undergone significant morphologic changes in-
cluding	neurodegeneration,	inflammation,	and	mossy	fiber	sprouting.
The	most	striking	effect	seen	in	this	study	was	the	kindling-	sensitive	
phenotype of Tom−/−	mice.	Significantly	fewer	stimuli	were	needed	to	
reach a fully kindled state in Tom−/−	mice	compared	to	controls.	Since	
the	AD	currents	were	not	different,	it	seems	credible	that	Tom−/− mice 
have a greater response to the same level of stimulation. In concert with 
this	observation,	the	MEA	measurements	of	naïve	animals	showed	that	
KCl-	evoked	glutamate	release	was	increased	in	Tom−/−	mice,	therefore	it	
is	plausible	that	each	stimulation	could	result	in	higher	glutamate	release,	
which could enhance the kindling process. This is perhaps not surprising 
since	our	previous	studies	with	VAMP-	2	heterozygous	mice	showed	a	
delay	in	kindling	and	a	decrease	in	glutamate	release	(Matveeva	et	al.,	
2012).	Thus,	our	data	imply	that	the	dysregulation	of	glutamate	release,	
whether	increased	or	decreased,	affects	the	kindling	process.
It	was	 expected	 that	 loss	 of	 STXBP5/tomosyn-	1	would	 also	 have	
increased	glutamate	release	in	kindled	mice;	however,	this	was	not	ob-
served.	Once	animals	were	kindled,	loss	of	STXBP5/tomosyn-	1	had	no	
effect.	There	are	several	potential	explanations	for	this	result.	First,	it	is	
possible	that	the	fully	kindled	state	represents	a	maximized	state	for	glu-
tamate	release	that	cannot	be	exceeded.	Thus,	the	increased	glutamate	
release measured in naïve Tom−/− mice cannot be observed in kindled 
animals because their release mechanisms are saturated as a result of 
kindling.	An	alternative	explanation	may	relate	to	the	small	sample	size	of	
kindled	animals	(n	=	3/genotype).	It	is	possible	that	our	lack	of	data	sup-
porting any genotype effect could be due to a type II error caused by the 
small	sample	size.	For	our	analysis	of	the	effect	of	kindling,	all	genotypes	
are collapsed to a population size of n	=	6;	thus,	the	observed	differences	
are more likely real and not a type I error since this aggregate sample size 
and	the	results	are	similar	to	findings	of	previous	studies	(Matveeva	et	al.,	
2012;	Rüden,	Jafari,	Bogdanovic,	Wotjak,	&	Potschka,	2015).
Kindling has been shown to increase blood pressure and cardiac 
arrhythmias	 thus	making	kindled	animals	prone	to	death	 (Goodman,	
Homan,	&	Crawford,	1990).	Tom−/−	mice,	especially	after	kindling,	were	
more	sensitive	to	the	manipulations	of	our	experiments.	Although	we	
did	 not	 have	 24	hr	 video	 surveillance,	we	 found	many	Tom−/− mice T
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dead in a messy cage with strewn feces and the animals themselves 
with	dried	saliva	and	blood	on	their	muzzles,	strongly	suggesting	sei-
zures	as	a	cause	of	death	and	the	consideration	of	a	murine	equivalent	
of	SUDEP	(sudden	unexpected	death	in	epilepsy).	Some	animals	died	
during	 kindling	 provoked	 seizures.	 In	 our	 study	 of	VAMP2	mutants	
(Matveeva	et	al.,	2012)	that	were	kindling	resistant,	we	did	not	observe	
this	 high	 level	 of	mortality	 associated	with	 the	 kindling	 stimulation,	
the	30-	day	postkindling	period,	or	during	subsequent	MEA	measure-
ments.	In	total,	67%	of	the	kindled	Tom−/− mice and 62.5% of the kin-
dled Tom+/+	mice	died	during	these	studies.	Another	potential	reason	
for	the	difference	in	mortality	between	the	VAMP2	and	STXBP5/to-
mosyn-	1	animals	may	relate	to	background,	since	the	VAMP-	2	mice	
were	on	a	pure	C57B/6	genetic	background.	As	in	the	previous	studies	
by	Sakisaka	et	al.,	2008,	we	used	null	animals	and	littermate	controls	
on	a	hybrid	genetic	background	of	C57B/6	and	BDF1.
The only genotype effect seen in this study was in the low basal 
glutamate levels seen in the kindled Tom−/− mice. This effect could be 
a compensatory response acting through presynaptic mGluR2/3 auto-
receptors	 (Rohde	et	al.,	 2012;	Watanabe	et	al.,	 2011).	 In	 support	of	
this	explanation,	we	previously	showed	that	resting	glutamate	levels	
are modulated with an mGluR2/3 agonist and antagonist in freely mov-
ing	animals	(Hascup	et	al.,	2010).	Alternatively,	there	is	also	evidence	
that	 kindling	 may	 increase	 neuropeptide	 Y	 which	 has	 been	 shown	
to	 decrease	 resting	 glutamate	 levels	 in	 the	 hippocampus	 (Botterill,	
Guskjolen,	Marks,	Caruncho,	&	Kalynchuk,	2015;	Klapstein	&	Colmers,	
1997;	Patrylo,	van	den	Pol,	Specer,	&	Williamson,	1999).	Furthermore,	
data	 suggest	 that	 the	NPY	Y2	 receptor	 is	 elevated	 in	 bilateral	 hilus	
and	the	NPY	Y1	receptor	 is	downregulated	 in	DG	30	days	following	
three	stage	5	seizures	of	hippocampal-	kindled	rats	(Gobbi	et	al.,	1998).	
Other	data	indicate	mice	with	NPY	gene	deletion	or	inactivation	show	
enhanced	susceptibility	to	seizures,	while	endogenous	overexpression	
of	 NPY	 protects	 from	 seizures	 and	 delays	 kindling	 epileptogenesis	
TABLE  3 Average	resting	glutamate	levels	for	kindled	Tom+/+ and 
Tom−/−	mice	in	the	whole	hippocampus	(mean	±	SEM)
Kindling status
Tom+/+ resting 
(μmol/L)
Tom−/− rest-
ing (μmol/L)
Naïve 1.7	±	0.20 1.9	±	0.20
Kindled 4.3	±	1.3 0.57	±	0.19a
ap < .05.
F IGURE  4 Spontaneous	glutamate	release	is	greater	in	the	ipsilateral	dentate	gyrus	of	kindled	mice.	All	measurements	are	presented	
as	mean	±	SEM	and	were	collected	from	both	naïve	(n	=	11)	and	kindled	(n	=	6)	mice.	These	composite	data	show	that	the	amplitude	of	
spontaneous glutamate release is significantly higher in the ipsilateral DG of kindled animals compared to all other ipsilateral and contralateral 
brain	regions	in	naïve	(white	bars)	and	kindled	(checkered	bars)	animals	except	the	contralateral	kindled	CA1	[F(2,	26)	=	6.9,	*p = .004; Bonferroni 
correction]
F IGURE  5 KCl-	evoked	glutamate	release	is	greater	in	the	DG	
of	kindled	mice.	All	measurements	as	scatter	plots	with	the	mean	
indicated	as	a	line	were	collected	in	naïve	(n	=	11)	and	kindled	(n	=	6)	
mice.	(a)	A	representative	trace	from	the	right	DG	of	kindled	(left)	and	
naïve	(right)	mice	for	KCl-	evoked	glutamate	release.	(b)	The	amplitude	
of	KCl-	evoked	glutamate	release	is	higher	in	the	DG	of	kindled	
animals	(left)	compared	to	the	DG,	CA3,	and	CA1	in	naïve	animals	
(right)	and	the	CA3	and	CA1	of	kindled	animals	[F(2,	26)	=	6.0,	
*p = .0073;	Bonferroni	correction].	The	white	circles	represent	Tom+/+ 
mice and the black circles represent Tom−/− mice. Notice how in the 
kindled animals there is no obvious trend for a genotype effect but 
there is an overall trend for a kindling effect
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(Richihi	 et	al.,	 2005).	 Thus,	 complicated	 GABA-	 and	 glutamatergic	
changes occur during kindling epileptogenesis that do not offer a 
ready	explanation	of	why	basal	levels	of	glutamate	are	less	in	kindled	
Tom−/− than kindled Tom+/+mice. That the diminution effect is only 
seen in kindled Tom−/− animals may be due to an interaction between 
their higher evoked glutamate release in the naïve state and repeated 
kindling	stimulations.	Considering	the	small	sample	sizes,	these	effects	
should be considered cautiously and more credence should be given 
to the kindling findings that were independent of a genotype.
Further	comment	should	be	made	regarding	potential	GABAergic	
mechanisms contributing to rapid epileptogenesis in the Tom−/− mice. 
Bragin,	Azizyan,	Almajano,	Wilson,	and	Engel	(2005)	have	shown	low-	
voltage	fast-	onset	(LVF)	and	hypersynchronous-	onset	(HYP)	spikes	pre-
ceding	spontaneous	seizures	in	freely	moving	rats	that	had	SE-	induced	
kainic	 acid	 hippocampal	 injections.	 Levesque,	 Salami,	 Gotman,	 and	
Avoli	(2012)	demonstrated	LVF	and	HYP	in	the	rat	pilocarpine	model	
of	TLE.	Avoli	 and	 colleagues	have	 recently	 studied	 the	equivalent	of	
LVF	and	HYP	seizures	in	an	in	vitro	slice	preparation	of	rat	perirhinal	
cortex	(Köhling	et	al.,	2016).	They	concluded	their	data	best	explained	
HYP	seizures	as	a	dynamic	weakening	of	GABAA receptor signaling. The 
artifact induced by the electrical kindling stimulus in our study obscures 
the initial components of the EEG trace making this model not amena-
ble	to	studying	LVP	and	HYP,	including	a	potential	GABAergic	mecha-
nism,	in	the	transition	from	the	preictal	to	the	ictal	state.
STXBP5/tomosyn-	1	may	 be	most	 important	 at	 regulating	 gluta-
mate	 early	 in	 kindling	 and	 epileptogenesis	 (Matveeva	 et	al.,	 2008);	
thus,	STXBP5/tomosyn-	1’s	absence	may	contribute	to	the	faster	pro-
gression we observed as well as to the increased evoked glutamate 
release seen in the naïve Tom−/− mice before kindling. Once an an-
imal	 is	 fully	 kindled,	 the	 effect	 of	 STXBP5/tomosyn-	1	 is	 not	 appar-
ent.	 It	 is	 formally	possible	 that	 tomosyn-	2	compensates	 for	 the	 loss	
of	STXBP5/tomosyn-	1	in	the	fully	kindled	state.	We	did	not	measure	
its	 levels.	However,	 tomosyn-	2	 is	 found	postsynaptically	 suggesting	
that it may play a role in synaptic plasticity independent of regulating 
neurotransmitter	release	(Barak	et	al.,	2010).
Others have shown that kindling increases glutamate release in the 
rat	hippocampus	(Geula,	Jarvie,	Logan,	&	Slevin,	1988;	Jarvie,	Logan,	
Geula,	&	Slevin,	1990;	Minamoto	et	al.,	1992).	Here	we	show	an	in-
crease in evoked and spontaneous glutamate release in the DG of the 
hippocampus in kindled mice. We have previously reported changes 
in	DG	glutamate	dynamics	in	kindled	animals	(Matveeva	et	al.,	2011,	
2012).	In	fact,	others	have	also	found	changes	in	the	DG	of	the	hippo-
campus	using	chemical	and	electrical	kindling	models	(Popova,	Aniol,	
Lazareva,	Yu,	&	Gulyaeva,	2013;	Sun	et	al.,	2013).	The	DG	is	consid-
ered	the	“gatekeeper”	of	the	trisynaptic	glutamatergic	throughput	of	
the	 hippocampus	 (Tamminga,	 Southcott,	 Sacco,	 Wagner,	 &	 Ghose,	
2012).	The	DG	also	has	a	high	rate	of	neurogenesis	 (Aimone,	Deng,	
&	Gage,	2011).	These	factors	may	make	the	DG	more	susceptible	to	
insults.	Also,	compensatory	responses	may	occur	downstream	in	CA3	
and	CA1	that	may	attenuate	glutamate	release;	this	could	explain	why	
no changes in glutamate release were observed in these areas. This is 
consistent with the spontaneous glutamate release dynamics seen in 
the	rat	hippocampus	we	previously	reported	(Matveeva	et	al.,	2012).	
Thus,	the	current	research	adds	to	the	preexisting	body	of	work	sug-
gesting that glutamate dysregulation in the DG is a primary driver of 
epileptogenesis.	Even	more	so,	 this	 research	highlights	 the	 fact	 that	
though proteins involved in regulating glutamate release may contrib-
ute	to	the	early	stages	of	epileptogenesis,	it	is	very	possible	that	some	
proteins are more important in the maintenance of this epileptic state 
once	an	animal	is	fully	kindled.	This	emphasizes	the	complexity	of	the	
molecular	mechanisms	 involved	 in	 epileptogenesis,	 and	 accentuates	
the fact that these proteins and their association with neurotransmit-
ter release need to be studied at many different time points in the ep-
ileptogenic process to fully understand the dynamic interactions that 
contribute to epileptogenesis.
We	 saw	 only	 minimal	 differences	 in	 the	 7SC	 complex,	 SV2,	 or	
NSF	in	this	study	that	did	not	reach	statistical	significance.	This	result	
was not as robust as our previous findings in several kindling models 
where	we	saw	changes	in	these	protein	complexes	in	the	hippocampi	
of	both	kindled	rats	and	mice	(Matveeva	et	al.,	2007,	2011,	2012).	In	
mice	we	observed	minor,	yet	significant,	increases	in	SV2	with	minimal	
changes	 in	NSF	while	observing	more	 robust	 alterations	 in	 the	7SC	
(Matveeva	et	al.,	2011).	Ohno	et	al.	(2009)	also	has	reported	a	prefer-
ential	increase	in	the	hippocampal	SV2A	following	pentylenetetrazole	
kindling. The lack of more robust changes in the present study may be 
related	to	strain	background	since	these	animals	were	not	on	a	C57Bl/J	
background.	Alternatively,	the	loss	of	STXBP5/tomosyn-	1	could	affect	
the	biochemical	changes	that	we	noted	previously.	However,	to	fully	
understand	 the	mechanism(s)	 for	 the	dampening	of	 the	protein	 and	
complex	changes,	more	experiments	are	needed.
In	summary,	these	data	suggest	Tom−/− mice progress through kin-
dling	 faster	 requiring	 fewer	 stimuli	 to	 reach	a	 fully	kindled	state	and	
that naïve Tom−/− animals do have higher evoked glutamate release 
compared to naïve Tom+/+	mice	before	kindling	occurs.	Furthermore,	
after	animals	have	reached	two	consecutive	Racine	stage	5	seizures,	
kindling	increases	the	amplitude	of	KCl-	evoked	and	spontaneous	glu-
tamate release in the DG. These results show the benefit of directly 
measuring glutamate in kindled and transgenic animals to understand 
how glutamate dynamics are involved in kindling and epileptogenesis 
and	highlight	the	complexity	of	protein–protein	interactions	in	regulat-
ing neurotransmitter dynamics throughout the epileptogenic process.
Recent	years	have	seen	the	emergence	of	the	concept	of	“synap-
topathies”,	 alterations	 in	 the	 neurotransmitter	 release	machinery,	 as	
a cause of certain human epilepsies. These include mutations in syn-
taxin-	1B	(STX1B),	SNAP-	25,	and	syntaxin	binding	protein	1	(STXBP1/
Munc	18-	1)	(Rohena	et	al.,	2013;	Saitsu,	Kato,	Mizuguchi,	Hamada,	&	
Osaka,	2008;	Schubert,	Siekierska,	Langlois,	May,	&	Huneau,	2014).	
The	current	study	of	kindling	facilitation	in	a	viable	STXBP5/tomosyn-	
1-	deficient	mouse	suggests	another	potential	synaptopathy	that	has	
not been described in humans.
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